Surgery Plus HIPEC Only ‘ Potential for Cure ’ of Peritoneal Mesothelioma
This study contributes to a better understanding of how CRS and HIPEC work and who is likely to receive the best benefit from this combination treatment.
For patients with the most aggressive peritoneal mesothelioma cancers, additional options — such as immunotherapy or ongoing, post-surgical delivery of chemotherapy into the peritoneal cavity — may be additional treatments to consider.
The post Surgery Plus HIPEC Only ‘Potential for Cure’ of Peritoneal Mesothelioma appeared first on Mesothelioma Center - Vital Services for Cancer Patients & Families.
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Matt Mauney Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Immunotherapy | Mesothelioma | Study